Thurs Jan 9th, the US Stock Markets will be closed in observance of a national day of mourning for former President Jimmy Carter. Read the press release here. Regular trading hours will resume tomorrow.
Smith & Nephew Snats ADR (SNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SNN | ABT | BSX | SYK | MDT |
| Company | Smith & Nephew Snats ADR | Abbott Laboratories | Boston Scientific Corp | Stryker Corp | Medtronic Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 24.25 | 113.54 | 96.68 | 361.30 | 80.41 |
| High | 24.44 | 114.31 | 97.13 | 364.95 | 83.22 |
| Low | 24.07 | 112.26 | 94.75 | 354.73 | 80.35 |
| Last | 24.32 | 114.25 | 95.95 | 364.10 | 82.68 |
| Change | -0.29 | +0.85 | +3.96 | +8.92 | +2.81 |
| % Change | -1.18% | +0.75% | +4.30% | +2.51% | +3.52% |
| Volume | 537,300 | 4,455,700 | 10,747,700 | 1,534,700 | 11,154,101 |
| 20-Day Average Volume | 965,830 | 4,828,370 | 4,925,375 | 1,237,300 | 6,236,395 |
| Previous Close | 24.61 | 113.40 | 91.99 | 355.18 | 79.87 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.87 | 113.73 | 90.46 | 366.50 | 81.19 |
| 20-Day Raw Stochastic | 13.97% | 58.12% | 88.08% | 35.22% | 70.48% |
| 20-Day Relative Strength | 36.82% | 48.81% | 69.19% | 45.99% | 48.22% |
| Weighted Alpha | -14.45 | +1.73 | +59.00 | +13.47 | -5.21 |
| Today's Opinion | 88% Sell | 24% Buy | 100% Buy | 24% Buy | 40% Sell |
| Previous Opinion | 88% Sell | 8% Buy | 100% Buy | 8% Buy | 56% Sell |
| Last Month's Opinion | 72% Sell | 64% Buy | 100% Buy | 88% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.06% since 12/31/24 | +1.01% since 12/31/24 | +7.42% since 12/31/24 | +1.12% since 12/31/24 | +3.51% since 12/31/24 |
| Low | 24.07 on 01/08/25 | 112.26 on 01/08/25 | 88.81 on 01/02/25 | 351.85 on 01/07/25 | 79.66 on 01/06/25 |
| High | 24.82 on 01/07/25 | 114.69 on 01/07/25 | 97.13 on 01/08/25 | 364.95 on 01/08/25 | 83.22 on 01/08/25 |
| 1-Month | |||||
| %Chg | -4.10% since 12/06/24 | -1.17% since 12/06/24 | +6.53% since 12/06/24 | -5.43% since 12/06/24 | -1.58% since 12/06/24 |
| Low | 24.07 on 01/08/25 | 111.28 on 12/19/24 | 87.25 on 12/20/24 | 351.85 on 01/07/25 | 79.29 on 12/30/24 |
| High | 25.98 on 12/09/24 | 116.39 on 12/10/24 | 97.13 on 01/08/25 | 386.63 on 12/11/24 | 84.41 on 12/09/24 |
| 3-Month | |||||
| %Chg | -14.58% since 10/08/24 | -0.33% since 10/08/24 | +11.78% since 10/08/24 | +3.79% since 10/08/24 | -6.19% since 10/08/24 |
| Low | 23.85 on 11/06/24 | 111.28 on 12/19/24 | 80.64 on 10/30/24 | 349.05 on 10/09/24 | 79.29 on 12/30/24 |
| High | 29.64 on 10/18/24 | 121.00 on 11/06/24 | 97.13 on 01/08/25 | 398.20 on 11/18/24 | 92.68 on 10/24/24 |
| 6-Month | |||||
| %Chg | -10.46% since 07/08/24 | +11.88% since 07/08/24 | +26.07% since 07/08/24 | +8.98% since 07/08/24 | +7.60% since 07/08/24 |
| Low | 23.85 on 11/06/24 | 99.71 on 07/18/24 | 71.88 on 08/05/24 | 314.93 on 08/05/24 | 75.96 on 07/09/24 |
| High | 31.72 on 09/09/24 | 121.00 on 11/06/24 | 97.13 on 01/08/25 | 398.20 on 11/18/24 | 92.68 on 10/24/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,632,461 | 198,161,472 | 141,413,696 | 138,800,752 | 106,019,408 |
| Shares Outstanding, K | 437,190 | 1,734,455 | 1,473,827 | 381,216 | 1,282,286 |
| Annual Sales | 5,549,000,000 | 40,109,000,000 | 14,240,000,000 | 20,498,000,000 | 32,364,000,000 |
| Annual Net Income | 263,000,000 | 5,723,000,000 | 1,591,000,000 | 3,165,000,000 | 3,677,000,000 |
| Last Quarter Sales | 1,249,000,000 | 10,635,000,000 | 4,209,000,000 | 5,494,000,000 | 8,403,000,000 |
| Last Quarter Net Income | 160,000,000 | 1,646,000,000 | 468,000,000 | 834,000,000 | 1,269,000,000 |
| 60-Month Beta | 0.84 | 0.73 | 0.80 | 0.95 | 0.83 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 02/05/15 | 1.21 on 10/16/24 | 0.63 on 10/23/24 | 2.87 on 10/29/24 | 1.26 on 11/19/24 |
| Latest Earnings Date | 02/25/25 | 01/22/25 | 02/05/25 | 01/28/25 | 02/18/25 |
| Most Recent Dividend | 0.273 on 10/04/24 | 0.550 on 10/15/24 | N/A | 0.840 on 12/31/24 | 0.700 on 12/27/24 |
| Next Ex-Dividends Date | 10/04/24 | 01/15/25 | N/A | 12/31/24 | 12/27/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.09 | 38.98 | 30.51 | 15.21 |